Lataa...
Polo-like kinase 3 inhibits glucose metabolism in colorectal cancer by targeting HSP90/STAT3/HK2 signaling
BACKGROUND: Polo-like kinase 3 (PLK3) has been documented as a tumor suppressor in several types of malignancies. However, the role of PLK3 in colorectal cancer (CRC) progression and glucose metabolism remains to be known. METHODS: The expression of PLK3 in CRC tissues was determined by immunohistoc...
Tallennettuna:
| Julkaisussa: | J Exp Clin Cancer Res |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6815449/ https://ncbi.nlm.nih.gov/pubmed/31655629 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-019-1418-2 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|